Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study - Mitsunaga, Keila; Bagot, Martine; Ram-Wolff, Caroline; Guenova, Emmanuella; von Gugelberg, Christina; Hodak, Emmilia; Amitay-Laish, Iris; Papadavid, Evangelia; Jonak, Constanze; Porkert, Stefanie; Scarisbrick, Julia; Applewaite, Rona; et al. (British journal of dermatology, 2024)
Online veröffentlicht: 10. April 2024